Maverick Simulation Solutions Ltd specialises in medical simulation technology solutions. The company was founded as Maveric Solution Inc., a 3D scanning and printing venture, in 2006. Almost a decade later, in 2019, it revamped itself and entered the medical and healthcare simulation industry.
In September 2023, it became a Public limited company. Maverick Simulations’ broad portfolio includes medical simulators like AI-powered patient simulators, an Anatomy Dissection table, task trainers and much more.
Key Financial Insights 2026
Particular
(FY2024-25) (₹ crore)
Annual Revenue
138.8
Net Profit / Loss
47.8
Total Equity
97
Cash Balance
7.24 Crores
(Note: Figures are estimates as per publicly available reports)
Maverick Simulation Solutions at a Glance
Here is an overview of Maverick Simulation Solutions Limited.
Over the years, Maverick Simulation Solutions Ltd have developed as a leading medical technology solutions provider. Let’s have a look at its origin and history.
The company was founded as Maveric Solution Inc by Anuj Chahal (Founder and Managing Director) and Kanika Chahal (Co-founder and Director). It focused on 3D scanning, reverse engineering, and prototyping for almost two decades till 2019.
2019: Shift to Healthcare Simulation
In 2019, almost a decade later, the company shifted its core business operations to healthcare simulation, introducing the Anatomage virtual dissection table in India through global collaboration.
2020-2022: Expanded its Product Portfolio
Maverick Simulation Solutions built an in-house R&D facility and launched products like LuSi & TestChest; started offering complete simulation lab solutions for institutions like AIIMS, IITs, etc.
2023: Incorporated as Maverick Simulation Solutions Ltd.
The firm was converted from private to public (Maverick Simulation Solutions Ltd.) in Sep 2023. This made the business scale for larger growth.
Electrical engineer with corporate experience (ABB, HCL, Airtel).
Dr. Sunil Tomar
Director (R&D)
30+ years of teaching and research experience.
Business and Operations
Maverick operates as a B2B, solution-oriented model in the healthcare education segment.
Products: It designs and sells hardware simulators across all fidelity levels. The offerings include 40+ products. These products often incorporate AI (Artificial Intelligence) /AR(Augmented Reality)/VR (Virtual Reality) technology.
Some of the key offerings are:
Task trainers (suture pads, arms for IV insertion)
Patient mannequins
Full-size adult/pediatric simulators with software.
High-end systems (like SIDDH)
Training & Services: The company offers various courses and training programs. It supports clients post-sale with curriculum development and maintenance. Training programs offered by Maverick Simulation:
NurseSim Pro: Advanced Simulation-based training for nurses
IVF Sim Pro: Learning advanced clinical skills
FaceSim Pro: Upgradation of dermatology skills
Financial Overview
Here is a brief financial overview of Maverick Simulation.
Financial Performance (FY24-FY25)
Particulars
(FY 2023-FY24) (₹ Crore)
(FY 2024-FY25) (₹ Crore)
Revenue
14.2
136.3
EBITDA
1.12
61.34
PAT
0.94
48
Balance Sheet Snapshot
Particulars
(FY 2023-FY24) (₹ Lakhs)
(FY 2024-FY25) (₹ Lakhs)
Non-Current Assets
883.39
756.06
Current Assets
7,833.77
15,588.70
Total Assets
8,717.76
16,345
Total Equity
2,556.45
9,700
Non-Current Liabilities
-
1,107.13
Current Liabilities
6,160.71
5,537.47
Total Liabilities
8,717.76
16,345
Cashflow Statement
Particulars
(FY 2023-FY24) (₹ Lakhs)
(FY 2024-FY25) (₹ Lakhs)
Operating Cash Flow
-2,039.33
-2,100.10
Investing Cash Flow
-834.76
-1,129.46
Financing Cash Flow
3,231.12
3,597
Net Cash change
357.03
367
Opening Cash & Cash Equivalents
-
357.03
Closing cash position
357.03
724.12
(Note: The Figures presented are estimates based on publicly available reports.)
Previous Funding History
Maverick Simulation Solutions Limited has not undergone any formal VC funding or public capital raise. It has been financed through:
Promoter Capital: Initial funding from founders’ investments during the private era (as Maveric Solutions).
Internal Reinvestment: The company has used the profits to strengthen its research and development expansion. This means the company remains founder‐financed. Its business scaling relies on organic growth and project credit, not on equity dilution.
Business USPs
Below are some key business USPs of Maverick Simulation Solutions Ltd.:
“Made-in-India” Innovation: Maverick Simulation Solutions Limited is best known as an Indian manufacturer of advanced medical simulators. It also collaborates with global leaders to maintain and ensure international quality standards.
Complete Simulation Ecosystems: Unlike standalone device vendors, Maverick delivers end-to-end training programs to make the learner well-versed with their simulators and products.
Tech Integration: The company involves modern tech, AI, AR/VR, and cloud analytics in its systems. Example: The new SIDDH simulator includes AI-powered ultrasound and real-time feedback.
Institutional Partnerships: Collaborations with AIIMS hospitals and other institutions enhance credibility and product development. The adoption by government medical colleges provides a strong base for the company to gain authority and trust in the industry.
Future Growth Plans
Maverick’s management has outlined ambitious expansion plans in recent years:
R&D Investment: Last year, in 2025, the company announced that it had budgeted an estimated amount of ₹50 Crore for R&D this year to fund next-gen simulators (integrating AI/ML) and new modules (e.g. pediatric, tele-simulation). In April 2026, it launched SIDDH (adult patient simulator). As per reports, it is a 65 kg full-body simulator that is aimed to replicate real-world medical scenarios and a real-time physiological response system.
Brand Building: The company is actively working for “Made in India” leadership and engaging academic partners. In various recent public appearances, the leadership team has directed that in the coming years, Maverick aims to become a national player in medical simulation. They aim to make it “not just a consumer but a creator and exporter” of simulation tech.
Recent Market Trends
India’s medical simulation market is growing rapidly for competency-based medical education, expansion of skills, and the need for safe, hands-on clinical training.
Maverick is well-positioned in this environment with its “Made in India” approach. The February 2026 launch of SIDDH directly addresses these trends. It is well supported by its vision to invest ₹50 crore in R&D focus and its presence as the medical simulator supplier among 100+ reputed medical institutions.
Disclaimer: The information provided is based on publicly available data, industry reports, and company announcements. Market size, growth rates, and projections are estimates and may vary across sources. Future performance depends on multiple factors, including regulatory changes, competition, and execution risks. Investors should conduct their own research before making any investment decisions.
Author: Komal Bhatt
Komal Bhatt is a finance content writer at InvestKraft, specialising in well-researched articles on financial products, stock markets, and investment opportunities, with a particular focus on unlisted shares.
She holds a Master’s degree in Commerce from the University of Delhi, which gives her a solid academic foundation in finance and business. With over three years of hands-on experience in creating digital finance content, Komal has developed a clear understanding of investor needs through her work on wealth management, NISM certification programs, and market education materials.
Komal is passionate when it comes to breaking down complex financial concepts into simple, accurate and actionable insights. Her goal is to help everyday investors understand markets better and make more informed decisions based on reliable, research-backed information.
amit@unlistedkraft.in
+91-9599071664
+91-9599071664
+91-9599071664
amit@unlistedkraft.in